1     
CONTROLLED SUBSTANCES AMENDMENTS

2     
2024 GENERAL SESSION

3     
STATE OF UTAH

4     
Chief Sponsor: Jennifer Dailey-Provost

5     
Senate Sponsor: Evan J. Vickers

6     

7     LONG TITLE
8     General Description:
9          This bill adds gabapentin to the list of controlled substances.
10     Highlighted Provisions:
11          This bill:
12          ▸     adds gabapentin to Schedule V of the list of controlled substances; and
13          ▸     makes technical and conforming changes.
14     Money Appropriated in this Bill:
15          None
16     Other Special Clauses:
17          None
18     Utah Code Sections Affected:
19     AMENDS:
20          58-37-4, as last amended by Laws of Utah 2022, Chapter 165
21     

22     Be it enacted by the Legislature of the state of Utah:
23          Section 1. Section 58-37-4 is amended to read:
24          58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
25     required -- Specific substances included in schedules.
26          (1) There are established five schedules of controlled substances known as Schedules I,
27     II, III, IV, and V which consist of substances listed in this section.

28          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
29     the official name, common or usual name, chemical name, or brand name designated:
30          (a) Schedule I:
31          (i) Unless specifically excepted or unless listed in another schedule, any of the
32     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
33     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
34     chemical designation:
35          (A) Acetyl-alpha-methylfentanyl
36     (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
37          (B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
38          (C) Acetylmethadol;
39          (D) Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);
40          (E) Allylprodine;
41          (F) Alphacetylmethadol, except levo-alphacetylmethadol also known as
42     levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
43          (G) Alphameprodine;
44          (H) Alphamethadol;
45          (I) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
46     propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
47          (J) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
48     piperidinyl]-N-phenylpropanamide);
49          (K) Benzylpiperazine;
50          (L) Benzethidine;
51          (M) Betacetylmethadol;
52          (N) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
53     piperidinyl]-N-phenylpropanamide);
54          (O) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
55     phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
56          (P) Betameprodine;
57          (Q) Betamethadol;
58          (R) Betaprodine;

59          (S) Butyryl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);
60          (T) Clonitazene;
61          (U) Cyclopropyl fentanyl
62     (N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
63          (V) Dextromoramide;
64          (W) Diampromide;
65          (X) Diethylthiambutene;
66          (Y) Difenoxin;
67          (Z) Dimenoxadol;
68          (AA) Dimepheptanol;
69          (BB) Dimethylthiambutene;
70          (CC) Dioxaphetyl butyrate;
71          (DD) Dipipanone;
72          (EE) Ethylmethylthiambutene;
73          (FF) Etizolam
74     (1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);
75          (GG) Etonitazene;
76          (HH) Etoxeridine;
77          (II) Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
78     furan-2-carboxamide);
79          (JJ) Furethidine;
80          (KK) Hydroxypethidine;
81          (LL) Ketobemidone;
82          (MM) Levomoramide;
83          (NN) Levophenacylmorphan;
84          (OO) Methoxyacetyl fentanyl
85     (2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);
86          (PP) Morpheridine;
87          (QQ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
88          (RR) Noracymethadol;
89          (SS) Norlevorphanol;

90          (TT) Normethadone;
91          (UU) Norpipanone;
92          (VV) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
93     propanamide);
94          (WW) Para-fluoroisobutyryl fentanyl
95     (N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
96          (XX) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
97          (YY) Phenadoxone;
98          (ZZ) Phenampromide;
99          (AAA) Phenomorphan;
100          (BBB) Phenoperidine;
101          (CCC) Piritramide;
102          (DDD) Proheptazine;
103          (EEE) Properidine;
104          (FFF) Propiram;
105          (GGG) Racemoramide;
106          (HHH) Tetrahydrofuran fentanyl
107     (N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
108          (III) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
109          (JJJ) Tilidine;
110          (KKK) Trimeperidine;
111          (LLL) 3-methylfentanyl, including the optical and geometric isomers
112     (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);
113          (MMM) 3-methylthiofentanyl
114     (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
115          (NNN) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also
116     known as U-47700; and
117          (OOO) 4-cyano CUMYL-BUTINACA.
118          (ii) Unless specifically excepted or unless listed in another schedule, any of the
119     following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
120     salts, isomers, and salts of isomers is possible within the specific chemical designation:

121          (A) Acetorphine;
122          (B) Acetyldihydrocodeine;
123          (C) Benzylmorphine;
124          (D) Codeine methylbromide;
125          (E) Codeine-N-Oxide;
126          (F) Cyprenorphine;
127          (G) Desomorphine;
128          (H) Dihydromorphine;
129          (I) Drotebanol;
130          (J) Etorphine (except hydrochloride salt);
131          (K) Heroin;
132          (L) Hydromorphinol;
133          (M) Methyldesorphine;
134          (N) Methylhydromorphine;
135          (O) Morphine methylbromide;
136          (P) Morphine methylsulfonate;
137          (Q) Morphine-N-Oxide;
138          (R) Myrophine;
139          (S) Nicocodeine;
140          (T) Nicomorphine;
141          (U) Normorphine;
142          (V) Pholcodine; and
143          (W) Thebacon.
144          (iii) Unless specifically excepted or unless listed in another schedule, any material,
145     compound, mixture, or preparation which contains any quantity of the following hallucinogenic
146     substances, or which contains any of their salts, isomers, and salts of isomers when the
147     existence of the salts, isomers, and salts of isomers is possible within the specific chemical
148     designation; as used in this Subsection (2)(a)(iii) only, "isomer" includes the optical, position,
149     and geometric isomers:
150          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
151     α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;

152          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
153     4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
154          (C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
155     2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
156          (D) 2,5-dimethoxyamphetamine, some trade or other names:
157     2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA;
158          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
159          (F) 4-methoxyamphetamine, some trade or other names:
160     4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA;
161          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
162          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
163     4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
164          (I) 3,4-methylenedioxy amphetamine;
165          (J) 3,4-methylenedioxymethamphetamine (MDMA);
166          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
167     alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
168          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
169     N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
170          (M) 3,4,5-trimethoxy amphetamine;
171          (N) Bufotenine, some trade and other names:
172     3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
173     N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
174          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
175          (P) Dimethyltryptamine, some trade or other names: DMT;
176          (Q) Ibogaine, some trade and other names:
177     7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
178     [5,4-b] indole; Tabernanthe iboga;
179          (R) Lysergic acid diethylamide;
180          (S) Marijuana;
181          (T) Mescaline;
182          (U) Parahexyl, some trade or other names:

183     3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
184          (V) Peyote, meaning all parts of the plant presently classified botanically as
185     Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
186     any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
187     preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
188          (W) N-ethyl-3-piperidyl benzilate;
189          (X) N-methyl-3-piperidyl benzilate;
190          (Y) Psilocybin;
191          (Z) Psilocyn;
192          (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
193     (cannabis plant), except for marijuana as defined in Subsection 58-37-2(1)(aa)(i)(E), as well as
194     synthetic equivalents of the substances contained in the cannabis plant, or in the resinous
195     extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their isomers with
196     similar chemical structure and pharmacological activity to those substances contained in the
197     plant, such as the following: Δ1 cis or trans tetrahydrocannabinol, and their optical isomers Δ6
198     cis or trans tetrahydrocannabinol, and their optical isomers Δ3,4 cis or trans
199     tetrahydrocannabinol, and its optical isomers, and since nomenclature of these substances is not
200     internationally standardized, compounds of these structures, regardless of numerical
201     designation of atomic positions covered;
202          (BB) Ethylamine analog of phencyclidine, some trade or other names:
203     N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
204     N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
205          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
206     1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
207          (DD) Thiophene analog of phencyclidine, some trade or other names:
208     1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
209          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
210          (iv) Unless specifically excepted or unless listed in another schedule, any material
211     compound, mixture, or preparation which contains any quantity of the following substances
212     having a depressant effect on the central nervous system, including its salts, isomers, and salts
213     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the

214     specific chemical designation:
215          (A) Mecloqualone; and
216          (B) Methaqualone.
217          (v) Any material, compound, mixture, or preparation containing any quantity of the
218     following substances having a stimulant effect on the central nervous system, including their
219     salts, isomers, and salts of isomers:
220          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
221     4,5-dihydro-5-phenyl-2-oxazolamine;
222          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
223     alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
224          (C) Fenethylline;
225          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
226     alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
227     alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
228     methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
229     optical isomers;
230          (E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
231          (F) N-ethylamphetamine; and
232          (G) N,N-dimethylamphetamine, also known as
233     N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
234          (vi) Any material, compound, mixture, or preparation which contains any quantity of
235     the following substances, including their optical isomers, salts, and salts of isomers, subject to
236     temporary emergency scheduling:
237          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
238          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
239          (vii) Unless specifically excepted or unless listed in another schedule, any material,
240     compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
241     (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
242          (b) Schedule II:
243          (i) Unless specifically excepted or unless listed in another schedule, any of the
244     following substances whether produced directly or indirectly by extraction from substances of

245     vegetable origin, or independently by means of chemical synthesis, or by a combination of
246     extraction and chemical synthesis:
247          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
248     opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
249     and their respective salts, but including:
250          (I) Raw opium;
251          (II) Opium extracts;
252          (III) Opium fluid;
253          (IV) Powdered opium;
254          (V) Granulated opium;
255          (VI) Tincture of opium;
256          (VII) Codeine;
257          (VIII) Ethylmorphine;
258          (IX) Etorphine hydrochloride;
259          (X) Hydrocodone;
260          (XI) Hydromorphone;
261          (XII) Metopon;
262          (XIII) Morphine;
263          (XIV) Oxycodone;
264          (XV) Oxymorphone; and
265          (XVI) Thebaine;
266          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
267     identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
268     substances may not include the isoquinoline alkaloids of opium;
269          (C) Opium poppy and poppy straw;
270          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
271     any salt, compound, derivative, or preparation which is chemically equivalent or identical with
272     any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
273     and salts of isomers and derivatives, whether derived from the coca plant or synthetically
274     produced, except the substances may not include decocainized coca leaves or extraction of coca
275     leaves, which extractions do not contain cocaine or ecgonine; and

276          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
277     liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
278          (ii) Unless specifically excepted or unless listed in another schedule, any of the
279     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
280     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
281     chemical designation, except dextrorphan and levopropoxyphene:
282          (A) Alfentanil;
283          (B) Alphaprodine;
284          (C) Anileridine;
285          (D) Bezitramide;
286          (E) Bulk dextropropoxyphene (nondosage forms);
287          (F) Carfentanil;
288          (G) Dihydrocodeine;
289          (H) Diphenoxylate;
290          (I) Fentanyl;
291          (J) Isomethadone;
292          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
293     levomethadyl acetate, or LAAM;
294          (L) Levomethorphan;
295          (M) Levorphanol;
296          (N) Metazocine;
297          (O) Methadone;
298          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
299          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
300     acid;
301          (R) Pethidine (meperidine);
302          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
303          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
304          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
305          (V) Phenazocine;
306          (W) Piminodine;

307          (X) Racemethorphan;
308          (Y) Racemorphan;
309          (Z) Remifentanil; and
310          (AA) Sufentanil.
311          (iii) Unless specifically excepted or unless listed in another schedule, any material,
312     compound, mixture, or preparation which contains any quantity of the following substances
313     having a stimulant effect on the central nervous system:
314          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
315          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
316          (C) Phenmetrazine and its salts; and
317          (D) Methylphenidate.
318          (iv) Unless specifically excepted or unless listed in another schedule, any material,
319     compound, mixture, or preparation which contains any quantity of the following substances
320     having a depressant effect on the central nervous system, including its salts, isomers, and salts
321     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
322     specific chemical designation:
323          (A) Amobarbital;
324          (B) Glutethimide;
325          (C) Pentobarbital;
326          (D) Phencyclidine;
327          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
328     1-piperidinocyclohexanecarbonitrile (PCC); and
329          (F) Secobarbital.
330          (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
331     compound, mixture, or preparation which contains any quantity of Phenylacetone.
332          (B) Some of these substances may be known by trade or other names:
333     phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
334          (vi) Nabilone, another name for nabilone:
335     (±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
336     6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
337          (vii) A drug product or preparation that contains any component of marijuana,

338     including tetrahydrocannabinol, and is approved by the United States Food and Drug
339     Administration and scheduled by the Drug Enforcement Administration in Schedule II of the
340     federal Controlled Substances Act, Title II, P.L. 91-513.
341          (c) Schedule III:
342          (i) Unless specifically excepted or unless listed in another schedule, any material,
343     compound, mixture, or preparation which contains any quantity of the following substances
344     having a stimulant effect on the central nervous system, including its salts, isomers whether
345     optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
346     and salts of isomers is possible within the specific chemical designation:
347          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
348     stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
349     listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
350     Code of Federal Regulations, and any other drug of the quantitive composition shown in that
351     list for those drugs or which is the same except that it contains a lesser quantity of controlled
352     substances;
353          (B) Benzphetamine;
354          (C) Chlorphentermine;
355          (D) Clortermine; and
356          (E) Phendimetrazine.
357          (ii) Unless specifically excepted or unless listed in another schedule, any material,
358     compound, mixture, or preparation which contains any quantity of the following substances
359     having a depressant effect on the central nervous system:
360          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
361     pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
362     which are not listed in any schedule;
363          (B) Any suppository dosage form containing amobarbital, secobarbital, or
364     pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
365     Administration for marketing only as a suppository;
366          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
367     salt of any of them;
368          (D) Chlorhexadol;

369          (E) Buprenorphine;
370          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
371     isomers, and salts of isomers, for which an application is approved under the federal Food,
372     Drug, and Cosmetic Act, Section 505;
373          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
374     ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
375          (H) Lysergic acid;
376          (I) Lysergic acid amide;
377          (J) Methyprylon;
378          (K) Sulfondiethylmethane;
379          (L) Sulfonethylmethane;
380          (M) Sulfonmethane; and
381          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
382     tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
383     2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
384     4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
385     flupyrazapon.
386          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
387     U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
388     (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
389     (-)-delta-9-(trans)-tetrahydrocannabinol.
390          (iv) Nalorphine.
391          (v) Unless specifically excepted or unless listed in another schedule, any material,
392     compound, mixture, or preparation containing limited quantities of any of the following
393     narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
394          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
395     milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
396     opium;
397          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
398     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
399     therapeutic amounts;

400          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
401     than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
402     alkaloid of opium;
403          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
404     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
405     recognized therapeutic amounts;
406          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
407     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
408     therapeutic amounts;
409          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
410     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
411     recognized therapeutic amounts;
412          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
413     more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
414     recognized therapeutic amounts; and
415          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
416     one or more active, non-narcotic ingredients in recognized therapeutic amounts.
417          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
418     including any of the following or any isomer, ester, salt, or derivative of the following that
419     promotes muscle growth:
420          (A) Boldenone;
421          (B) Chlorotestosterone (4-chlortestosterone);
422          (C) Clostebol;
423          (D) Dehydrochlormethyltestosterone;
424          (E) Dihydrotestosterone (4-dihydrotestosterone);
425          (F) Drostanolone;
426          (G) Ethylestrenol;
427          (H) Fluoxymesterone;
428          (I) Formebulone (formebolone);
429          (J) Mesterolone;
430          (K) Methandienone;

431          (L) Methandranone;
432          (M) Methandriol;
433          (N) Methandrostenolone;
434          (O) Methenolone;
435          (P) Methyltestosterone;
436          (Q) Mibolerone;
437          (R) Nandrolone;
438          (S) Norethandrolone;
439          (T) Oxandrolone;
440          (U) Oxymesterone;
441          (V) Oxymetholone;
442          (W) Stanolone;
443          (X) Stanozolol;
444          (Y) Testolactone;
445          (Z) Testosterone; and
446          (AA) Trenbolone.
447          (vii) Anabolic steroids expressly intended for administration through implants to cattle
448     or other nonhuman species, and approved by the Secretary of Health and Human Services for
449     use, may not be classified as a controlled substance.
450          (viii) A drug product or preparation that contains any component of marijuana,
451     including tetrahydrocannabinol, and is approved by the United States Food and Drug
452     Administration and scheduled by the Drug Enforcement Administration in Schedule III of the
453     federal Controlled Substances Act, Title II, P.L. 91-513.
454          (ix) Nabiximols.
455          (d) Schedule IV:
456          (i) Unless specifically excepted or unless listed in another schedule, any material,
457     compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
458     less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
459          (ii) Unless specifically excepted or unless listed in another schedule, any material,
460     compound, mixture, or preparation which contains any quantity of the following substances,
461     including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and

462     salts of isomers is possible within the specific chemical designation:
463          (A) Alprazolam;
464          (B) Barbital;
465          (C) Bromazepam;
466          (D) Butorphanol;
467          (E) Camazepam;
468          (F) Carisoprodol;
469          (G) Chloral betaine;
470          (H) Chloral hydrate;
471          (I) Chlordiazepoxide;
472          (J) Clobazam;
473          (K) Clonazepam;
474          (L) Clorazepate;
475          (M) Clotiazepam;
476          (N) Cloxazolam;
477          (O) Delorazepam;
478          (P) Diazepam;
479          (Q) Dichloralphenazone;
480          (R) Estazolam;
481          (S) Ethchlorvynol;
482          (T) Ethinamate;
483          (U) Ethyl loflazepate;
484          (V) Fludiazepam;
485          (W) Flunitrazepam;
486          (X) Flurazepam;
487          (Y) Halazepam;
488          (Z) Haloxazolam;
489          (AA) Ketazolam;
490          (BB) Loprazolam;
491          (CC) Lorazepam;
492          (DD) Lormetazepam;

493          (EE) Mebutamate;
494          (FF) Medazepam;
495          (GG) Meprobamate;
496          (HH) Methohexital;
497          (II) Methylphenobarbital (mephobarbital);
498          (JJ) Midazolam;
499          (KK) Nimetazepam;
500          (LL) Nitrazepam;
501          (MM) Nordiazepam;
502          (NN) Oxazepam;
503          (OO) Oxazolam;
504          (PP) Paraldehyde;
505          (QQ) Pentazocine;
506          (RR) Petrichloral;
507          (SS) Phenobarbital;
508          (TT) Pinazepam;
509          (UU) Prazepam;
510          (VV) Quazepam;
511          (WW) Temazepam;
512          (XX) Tetrazepam;
513          (YY) Tramadol;
514          (ZZ) Triazolam;
515          (AAA) Zaleplon; and
516          (BBB) Zolpidem.
517          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
518     any quantity of the following substances, including its salts, isomers whether optical, position,
519     or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
520     isomers is possible.
521          (iv) Unless specifically excepted or unless listed in another schedule, any material,
522     compound, mixture, or preparation which contains any quantity of the following substances
523     having a stimulant effect on the central nervous system, including its salts, isomers whether

524     optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
525     isomers, and salts of isomers is possible within the specific chemical designation:
526          (A) Cathine ((+)-norpseudoephedrine);
527          (B) Diethylpropion;
528          (C) Fencamfamine;
529          (D) Fenproprex;
530          (E) Mazindol;
531          (F) Mefenorex;
532          (G) Modafinil;
533          (H) Pemoline, including organometallic complexes and chelates thereof;
534          (I) Phentermine;
535          (J) Pipradrol;
536          (K) Sibutramine; and
537          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
538          (v) Unless specifically excepted or unless listed in another schedule, any material,
539     compound, mixture, or preparation which contains any quantity of dextropropoxyphene
540     (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
541          (vi) A drug product or preparation that contains any component of marijuana and is
542     approved by the United States Food and Drug Administration and scheduled by the Drug
543     Enforcement Administration in Schedule IV of the federal Controlled Substances Act, Title II,
544     P.L. 91-513.
545          (e) Schedule V:
546          (i) Any compound, mixture, or preparation containing any of the following limited
547     quantities of narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid,
548     which includes one or more non-narcotic active medicinal ingredients in sufficient proportion
549     to confer upon the compound, mixture, or preparation valuable medicinal qualities other than
550     those possessed by the narcotic drug alone:
551          (A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
552          (B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
553     grams;
554          (C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100

555     grams;
556          (D) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
557     atropine sulfate per dosage unit;
558          (E) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
559          (F) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
560     atropine sulfate per dosage unit; and
561          (G) unless specifically exempted or excluded or unless listed in another schedule, any
562     material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
563     effect on the central nervous system, including its salts, isomers, and salts of isomers.
564          (ii) A drug product or preparation that contains any component of marijuana, including
565     cannabidiol, and is approved by the United States Food and Drug Administration and
566     scheduled by the Drug Enforcement Administration in Schedule V of the federal Controlled
567     Substances Act, Title II, P.L. 91-513.
568          (iii) Gabapentin.
569          Section 2. Effective date.
570          This bill takes effect on May 1, 2024.